According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are C$13.84 Billion. In 2023 the company made an earning of C$6.01 Billion a decrease over its 2022 earnings that were of C$6.95 Billion. The earnings displayed on this page is the company's Pretax Income.